Qualitative Behavioral Analysis for Clinical Research
Extract clinical insights from patient interviews, transcripts & qualitative trial data
What You Can Do
You transform raw qualitative data into structured, clinically validated insights using industry-standard methods like thematic analysis and content analysis. This skill helps you codify patient verbatims into behavioral pattern inventories, adherence barrier frameworks, and intervention-ready evidence that supports trial design, protocol refinement, and regulatory submissions.
Features
automatically identify and hierarchically organize recurring themes from interview transcripts and open-ended responses
extract and categorize patient-reported obstacles to treatment compliance, protocol adherence, and retention
codify triggers, decision-making drivers, and behavioral mechanisms from qualitative narratives
surface why patients enroll, disengage, or struggle with trial participation through systematic verbatim analysis
convert open-ended survey and interview data into quantifiable behavioral categories for statistical modeling
produce audit-ready matrices linking source quotes to themes, facilitating regulatory submissions and cross-team collaboration
identify emergent patient-reported side effects, burden concerns, and unmet needs from qualitative sources
extract evidence-based mechanisms and actionable insights to inform intervention design and refinement
Example Output
Example 1: Adherence Barrier Analysis Input: 12 patient interview transcripts on diabetes medication adherence Output:
Top Adherence Barriers (coded):
- Forgetfulness (n=8, 67%): "I just forget to take it with breakfast"
- Cost concerns (n=6, 50%): "My copay went up, so I skip doses"
- Asymptomatic disease perception (n=5, 42%): "I feel fine, so why take it?"
- Side effect burden (n=4, 33%): "The nausea makes me skip it some days"
Example 2: Recruitment Challenge Themes Input: Focus group transcript from trial screen-fail population Output:
Key Enrollment Barriers:
- Health literacy gap: Patients misunderstood eligibility criteria; complexity of protocol language deterred participation
- Travel burden: Rural participants cited 90+ minute clinic commute as primary drop reason
- Mistrust of research: Historical trauma narratives emerged; trust-building messaging recommended
Example 3: Patient-Reported Outcome Categorization Input: 50 open-ended survey responses on treatment side effects Output:
Emerging Safety Themes (prioritized):
- Gastrointestinal (28%): nausea, bloating, constipation
- Cognitive (16%): "brain fog," difficulty concentrating
- Mood changes (12%): irritability, anxiety (novel signal)
What's Included
- SKILL.md instruction file: structured prompt for systematic qualitative analysis
- Thematic coding checklist: step-by-step framework for identifying, organizing, and validating themes
- Adherence barrier inventory template: pre-built categories for common barriers in clinical populations
- Coded data matrix template: Excel/CSV structure for organizing quotes, codes, themes, and source documentation
- Behavioral pathway mapping worksheet: framework for extracting patient decision-making triggers and intervention opportunities
Who It's For
- Clinical Research Scientists — designing trials, analyzing patient feedback, and refining protocols based on qualitative insights
- Patient Outcomes Researchers — extracting behavioral patterns and burden-of-disease themes from PRO data
- Behavioral Intervention Designers — grounding intervention logic in patient-reported mechanisms and barriers from qualitative evidence
- Regulatory Affairs Specialists — compiling qualitative evidence summaries for IND submissions and post-hoc trial analyses
- Recruitment & Retention Managers — identifying enrollment obstacles and disengagement drivers through systematic patient narrative analysis
Best For
- Analyzing trial dropout and screen-failure interviews to identify retention barriers
- Coding open-ended Patient-Reported Outcome (PRO) survey responses for quantitative modeling
- Extracting behavioral mechanisms from patient interviews to ground behavioral intervention design
- Identifying emergent safety signals and tolerability concerns from qualitative trial data
- Creating audit-ready coded data matrices and theme hierarchies for regulatory submissions
You might also like
You can architect end-to-end bioinformatics analysis pipelines by translating your research question into algorithmic approaches, selecting and optimizing appropriate tools and parameters for your dataset, and validating results against biological expectations. This skill guides you through the complete decision tree from raw data to publication-ready interpretation, helping you avoid parameter overfitting, misinterpreted statistical thresholds, and algorithm selection errors that compromise research validity.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
You can upload or describe product designs and receive a comprehensive analysis of manufacturing feasibility, cost drivers, and prioritized optimization recommendations. The skill identifies design inefficiencies, material waste opportunities, assembly complexity challenges, and supply chain risks—giving you actionable steps to reduce costs and prevent production delays before they happen.
by kody-w
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
Upload production cycle time data and Claude will identify process bottlenecks, calculate efficiency metrics, and automatically generate detailed SOPs. You'll get a complete analysis of where time is wasted and structured work instructions that your team can immediately implement to reduce cycle time and improve consistency.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-w